Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Delivery technologies for human vaccines.

Philippe Moingeon¹, Charles de Taisne, Jeffrey Almond

¹Aventis Pasteur SA, Research and Development, Marcy l'Etoile, France.

British Medical Bulletin

|August 15, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Digital twins to accelerate target identification and drug development for immune-mediated disorders.

FEBS open bio·2026

Same author

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.

Annals of the rheumatic diseases·2025

Same author

Identifying Therapeutic Targets for Amyotrophic Lateral Sclerosis Through Modeling of Multi-Omics Data.

International journal of molecular sciences·2025

Same author

Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis.

The FEBS journal·2025

Same author

Genetic markers for knee osteoarthritis presence are not associated with disease progression - data from the IMI-APPROACH cohort.

PloS one·2025

Same author

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI).

Annals of the rheumatic diseases·2025

Researchers are developing advanced vaccine delivery systems to improve immune responses for disease prevention and treatment. This review covers adjuvants, antigen vectors, and novel administration devices in late-stage human vaccine development.

Area of Science:

Vaccinology
Immunology
Biotechnology

Background:

Intense research focuses on novel vaccine delivery systems.
The goal is to optimize antigen presentation for effective immune responses.
Approaches range from empirical methods to rational designs mimicking natural infections.

Purpose of the Study:

To review late-stage developments in human vaccine delivery systems.
To categorize and discuss current advanced approaches in vaccine formulation and administration.
To provide an overview of innovative strategies for enhancing vaccine efficacy.

Main Methods:

Review of three main categories of vaccine delivery systems: adjuvants and formulations, antigen vectors (live attenuated microorganisms, synthetic vectors), and novel administration devices.

Related Experiment Videos

Focus on late-stage developments relevant to human vaccination.

Synthesis of current research trends and findings.

Main Results:

Adjuvants and formulations enhance immunogenicity and tailor immune responses.
Antigen vectors, including live and synthetic options, offer targeted antigen delivery.
Novel devices aim to improve vaccine administration efficiency and patient compliance.

Conclusions:

Optimized vaccine delivery systems are crucial for effective disease prevention and treatment.
Continued innovation in adjuvants, vectors, and administration devices is advancing human vaccinology.
Late-stage developments show promise for next-generation vaccines.